» Articles » PMID: 39861032

Targeting T-Cell Activation for Malaria Immunotherapy: Scoping Review

Overview
Journal Pathogens
Date 2025 Jan 25
PMID 39861032
Authors
Affiliations
Soon will be listed here.
Abstract

Malaria remains a critical global health issue due to high mortality rates, drug resistance, and low treatment efficacy. The genetic variability of proteins complicates the development of long-lasting immunity, as it impedes the human immune system's ability to sustain effective responses. T cells play a crucial role in combating malaria, but the parasite's complex life cycle-spanning liver and blood stages-presents significant challenges in effectively activating and targeting these cells. Immunotherapy, which enhances the immune response and promotes durable T cell activity, offers a promising avenue for more effective and lasting malaria treatments. This review systematically analyzed 63 studies published in the last decade, focusing on the role of T cells in malaria. Among the studies, 87.2% targeted T cells as immunotherapy candidates, with CD4+ and CD8+ T cells each accounting for 47.6% of the studies. γδ T cells were the focus in 7.9% of cases, while 12.7% explored non-T cell contributions to enhancing T cell-mediated responses. The findings underscore the potential of T cells, particularly CD8+ T cells, in liver-stage defense and advocate for the exploration of advanced vaccine platforms and novel therapies, such as mRNA-based vectors and monoclonal antibodies.

References
1.
Opata M, Carpio V, Ibitokou S, Dillon B, Obiero J, Stephens R . Early effector cells survive the contraction phase in malaria infection and generate both central and effector memory T cells. J Immunol. 2015; 194(11):5346-54. PMC: 4433766. DOI: 10.4049/jimmunol.1403216. View

2.
Kurup S, Obeng-Adjei N, Anthony S, Traore B, Doumbo O, Butler N . Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. Nat Med. 2017; 23(10):1220-1225. PMC: 5649372. DOI: 10.1038/nm.4395. View

3.
Pattinson D, Apte S, Wibowo N, Chuan Y, Rivera-Hernandez T, Groves P . Chimeric Murine Polyomavirus Virus-Like Particles Induce Antigen-Specific CD8 T Cell and Antibody Responses. Front Cell Infect Microbiol. 2019; 9:215. PMC: 6593135. DOI: 10.3389/fcimb.2019.00215. View

4.
Lau L, Fernandez-Ruiz D, Mollard V, Sturm A, Neller M, Cozijnsen A . CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria. PLoS Pathog. 2014; 10(5):e1004135. PMC: 4031232. DOI: 10.1371/journal.ppat.1004135. View

5.
Venkatraman N, Anagnostou N, Bliss C, Bowyer G, Wright D, Lovgren-Bengtsson K . Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. Vaccine. 2017; 35(45):6208-6217. DOI: 10.1016/j.vaccine.2017.09.028. View